New AlertSite API Monitoring Support for OpenAPI Drives Standardization from Design to Deployment
SOMERVILLE, Mass. – Feb. 13, 2018 – SmartBear, the leader in software quality tools for teams, today announced support for OpenAPI Specification (OAS) in AlertSite, a market leader in performance monitoring for web, mobile, cloud, and API. The new OpenAPI support in AlertSite allows teams to leverage their existing OpenAPI Specification (formerly known as the Swagger Specification) files to create API monitors seamlessly and instantly, driving standardization from design to deployment.
As the API economy continues to grow, API teams are increasingly adopting the OpenAPI Specification in order to standardize their APIs and improve maintenance, adoption, and consumption. However, many teams lack the time or expertise to implement an API monitoring tool to ensure their APIs function as designed once they are deployed. With the new OpenAPI support in AlertSite, development and operations teams can instantly create API monitors from their existing OAS files, thereby extending OAS standardization from design to deployment and gaining actionable insights into the performance and availability of their APIs.
A global leader in the hospitality industry leveraged the new OAS support in AlertSite to create monitors for their global API infrastructure in under a minute. Using the existing OAS files the development team had designed, their operations team was able to start monitoring their APIs immediately. As a result, they were able to gain full visibility into the health of their API infrastructure, which proved to be indispensable because their APIs build the foundation of their digital presence, and understanding how they’re performing provides true insight into the state of their digital applications as a whole.
“The support for the OpenAPI Specification bridges the gap between development and operational teams, optimizing DevOps initiatives by reusing the OAS designs to monitor their APIs in pre- and post-production,” said Anand Sundaram, Vice President of Products, AlertSite at SmartBear. “With the ability to monitor APIs throughout the entire API lifecycle, AlertSite makes it fast and easy to adopt an API monitoring strategy that works for your entire business, not just one department.”
The new support for the OAS in AlertSite builds on existing API monitoring integrations with SoapUI and SoapUI Pro, and is the first of several new API monitoring integrations and functionalities planned for 2018. In addition to AlertSite, SmartBear also provides several other API lifecycle tools that help you create and deliver great APIs, including SwaggerHub for designing, developing, and documenting APIs using the OpenAPI Specification, Swagger Inspector for testing and instantly generating OAS files for any API, SoapUI and SoapUI Pro for REST and SOAP functional testing and test automation, LoadUI Pro for API load testing, and ServiceV Pro for API and database virtualization.
To learn more about OpenAPI Specification support in AlertSite:
To explore your API Monitoring options read more here:
AlertSite from SmartBear is an intuitive tool used to monitor APIs, web applications, and mobile performance. With its intelligent alerting system, codeless scripting, and internal and external monitoring options, AlertSite provides a 360° view into the performance health and functional correctness of business critical digital assets. For more information, visit https://smartbear.com/product/alertsite/overview/ and follow @AlertSite on Twitter.
About SmartBear Software
Supporting more than six million software professionals and over 22,000 companies in 194 countries, SmartBear is the leader in software quality tools for teams. The company’s products help deliver the highest quality and best performing software possible while helping teams ship code at nearly impossible velocities. With products for API testing, UI testing, code review and performance monitoring across mobile, web and desktop applications, SmartBear equips every development, testing and operations team member with the tools to ensure quality at every stage of the software cycle. For more information, visit: http://smartbear.com, or for the SmartBear community, go to: LinkedIn, Twitter or Facebook.
BroadPR for SmartBear Software
Assembly Row, 450 Artisan Way
Somerville, MA 02145
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release New AlertSite API Monitoring Support for OpenAPI Drives Standardization from Design to Deployment here
News-ID: 942081 • Views: 621
More Releases from SmartBear Software
SmartBear to Offer Unmatched GraphQL Support and Enhanced UX with Release of Rea …
https://smartbear.com/news/news-releases/smartbear-to-offer-unmatched-graphql-support-and-e/ ReadyAPI 3.0 focuses on increased efficiency for software teams tasked with accelerating the testing and delivery of high-quality APIs SOMERVILLE, Mass. – Nov. 12, 2019 – SmartBear, the driver behind the industry’s leading tools for ensuring quality software delivery, has released ReadyAPI 3.0. This latest release addresses the increasing requirement for organizations to consistently deliver high-quality APIs in order to meet accelerated business demands within compressed release cycles.
SmartBear Expands Leadership Team with New CMO, Product and Marketing Executives …
https://smartbear.com/news/news-releases/smartbear-expands-leadership-team-with-new-cmo,-pr/ SmartBear Hires Tech Marketing Veteran Cynthia Gumbert as CMO to Support Expanding Markets and Rapid Growth SOMERVILLE, Mass. — July 10, 2019 — SmartBear, the innovator behind the industry’s highest impact tools to build, test, and monitor great software, has strengthened its leadership team with several new additions, including Cynthia Gumbert as Chief Marketing Officer. Additionally, Emmanuel Paraskakis joins the company as Vice President of Product Management, Courtney Cunnane as
SmartBear Further Strengthens Leadership Position by Bringing New Test Automatio …
https://smartbear.com/news/news-releases/smartbear-further-strengthens-leadership-position/ SmartBear Announces New Product Integrations and Functionality to Streamline Development by Bringing Together the Power of Test Automation and Test Management with Native Jira Experience SOMERVILLE, Mass. — April 10, 2019 — SmartBear, the innovator behind the industry’s highest impact tools to build, test, and monitor great software, announced four new product integrations between its test management solution, Zephyr, and its leading test automation tools, SoapUI Pro, TestComplete, CrossBrowserTesting, and
SmartBear Goes All In at Atlassian Summit 2019 in Las Vegas
https://smartbear.com/news/news-releases/smartbear-goes-all-in-at-atlassian-summit-2019/ SmartBear Goes All In at Atlassian Summit 2019 in Las Vegas SmartBear Experts Hit the Stage, Offer Personalized Demos, and Give out Envy-Inducing Prizes at Atlassian Summit – April 9-11, 2019 – Las Vegas SOMERVILLE, Mass. - April 05, 2019 - SmartBear, the innovator behind the industry’s highest impact tools to build, test, and monitor great software, is going all in at Atlassian Summit 2019, taking place on Tuesday, April
More Releases for API
Tagraxofusp - API Insight, 2018
Tagraxofusp, sold under the brand name of Elzonris, is an Interleukin 3 (IL-3) conjugated truncated diphtheria toxin. It is composed of catalytic and translocation domains of diphtheria toxin fused via Met-His linker to a full-length human IL-3. Download the sample report @ https://www.pharmaproff.com/request-sample/1168 Tagraxofusp was developed by Stemline Therapeutics Inc. and was approved in December 2018, as the first therapy for blastic plasmacytoid dendritic cell neoplasm. This drug achieved approval after
Cabozantinib- API Insight, 2018
Cabozantinib, sold under the brand name of Cabometyx and Cometriq, is used for the treatment of medullary thyroid cancer and a second line treatment for renal cell carcinoma. It is a small molecule inhibitor of the tyrosine kinases c-Met and VEGFR2, and also inhibits AXL and RET. Download the sample report @ https://www.pharmaproff.com/request-sample/1164 Discovered and developed by Exelixis Inc., its side-effects include increased liver enzymes, diarrhea, low calcium, mouth sores, decreased
Tyk API Management v2.3
After months working-out in the gym, the new version of Tyk is ready to flex its muscles. Tyk v2.3 is twice as fast, leaner, more extendable and is still available for FREE! London, United Kingdom 8th December, 2016. Tyk Technologies is pleased to announce the v2.3 release of Tyk, the popular open-source API Management platform. Tyk v2.3 builds upon the success of previous releases. The feedback and contributions from Tyk’s thriving open source community, as well as enterprise clients, drove
Telecom API Helps Application Developers to Integrate Various API Services
Telecom API market represents an overall Application Programming Interface (API) services provided by telecom carriers, service providers and aggregators to application developers in order to create mobile applications. Telecom API helps application developers to integrate various services such as payment, voice, SMS and WebRTC into their mobile application. This helps application developers to enhance their customer experience and market their mobile applications among end-users. Telecom API provides many benefits to
Biotech API Surging Worldwide
According to a new research report by RNCOS, entitled “Global Biotech API Market Analysis”, geographies across the world are showing insurgent growth in the biotech API Industry. The US occupied more than half of the share in the global market in 2011, and is the largest producer of biotech APIs. Western European countries occupy around 15% share globally among which, the UK is the largest producer of biotechnology-based APIs. The
Global Biotech API Market Analysis
RNCOS has recently added a new Market Research Report titled, “Global Biotech API Market Analysis” to its report gallery. Biotech APIs contribute a very low share in the global API market with synthetic API’s accounting for majority of the formulations. However, with the revolutionary growth in the biopharmaceutical industry and gaining applications of biotech drugs, biotech API’s are sure to see a highly prospective market in the future. As per our